CN105878430A - Anti-inflammatory buccal tablet for gingival damage - Google Patents
Anti-inflammatory buccal tablet for gingival damage Download PDFInfo
- Publication number
- CN105878430A CN105878430A CN201610470287.3A CN201610470287A CN105878430A CN 105878430 A CN105878430 A CN 105878430A CN 201610470287 A CN201610470287 A CN 201610470287A CN 105878430 A CN105878430 A CN 105878430A
- Authority
- CN
- China
- Prior art keywords
- inflammatory
- buccal tablet
- gingiva
- borax
- lozenge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/264—Aristolochia (Dutchman's pipe)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses an anti-inflammatory buccal tablet for gingival damage. The anti-inflammatory buccal tablet for gingival damage is prepared after grinding unprocessed Radix Aconiti Kusnezoffii, borneol, Herba Asari and borax into powder. The anti-inflammatory buccal tablet for gingival damage can act on an affected part directly and is capable of sterilizing, diminishing inflammation, promoting healing and reducing discomfort of the affected part.
Description
Technical field
The present invention relates to a kind of for treating gingiva breakage anti-inflammatory lozenge.
Background technology
Gingiva breakage is common a kind of oral disease, can cause after gingiva breakage formed between gum lobe and corona deeper
In lacuna, food debris and antibacterial easily caulked enters, clear up by the method brushed teeth or gargle, it is also difficult to food debris is clear
Reason, also can produce the most unpleasant abnormal flavour.Owing to gingiva breakage has swelling excitement, patient can go by automatic tongue
Lick affected part, so will result in gingiva breakage and be more difficult to heal.
Existing method is based on oral anti-inflammatory drug, and the method takes effect slowly, and medicine can not go directly affected part.
Summary of the invention
The deficiency existed for prior art, it is an object of the invention to provide one and has anti-inflammation and faint anesthesia
The anti-inflammatory lozenge of effect, can have and effectively carry out anti-inflammation and sterilization, anaesthetize affected part sensory nerve simultaneously, thus reduce affected part
Swelling excitement, prevent patient because the stimulation in affected part is automatic licks affected part, the beneficially healing at sufferer.
The technical scheme is that and be achieved in that: gingiva breakage anti-inflammatory lozenge forms by four kinds of following mass parts
Pulverizing and last make oral buccal tablet, four kinds of components are: Radix Aconiti Kusnezoffii 8-11, Borneolum Syntheticum 5-15, Herba Asari 2-8, Borax 4-10.
Compared to existing technology, this anti-inflammatory lozenge has the advantages that
1. anti-inflammatory lozenge can be directly good to affected part release medication effect.
2. can effectively anaesthetize affected part, eliminate swelling excitement, reduce the sense of discomfort of patient.
Detailed description of the invention:
Gingiva breakage anti-inflammatory lozenge is formed by four kinds of following mass parts to pulverize last makes oral buccal tablet, four kinds of components
For: Radix Aconiti Kusnezoffii 8-11, Borneolum Syntheticum 5-15, Herba Asari 2-8, Borax 4-10.
Several preferred embodiments of given below medicine.
Radix Aconiti Kusnezoffii 8, Borneolum Syntheticum 5, Herba Asari 2, Borax 4.
Radix Aconiti Kusnezoffii 9, Borneolum Syntheticum 7, Herba Asari 5, Borax 6.
Radix Aconiti Kusnezoffii 11, Borneolum Syntheticum 15, Herba Asari 8, Borax 10.
Above-mentioned mass parts namely the proportionate relationship of individual component.
Using method: identical with common anti-inflammatory lozenge using method, is directly contained in mouth.Every day 35 times, according to gingiva
Affected part situation regulation dosage.
Introduce feature and the control effect and mechanism of each component individually below.
Radix Aconiti Kusnezoffii: acrid in the mouth, hardship, property heat.There is narcotic analgesic, effect that spasmolytic is only jerked.Containing aconitine to mucocutaneous
Sensory nerve ending produce inhibitory action and in local anesthesia effect.Medicine acts on affected part, can narcotic analgesic for a long time,
Reduce the swelling excitement in affected part.
Borneolum Syntheticum: acrid in the mouth, hardship, is slightly cold.There is bactericidal antiphlogistic, effect of clearing away heat to alleviate pain.There is powerful transdermal function, containing left-handed dragon
Half triterpenoid such as terpene component and pier fruit acid alphitolic acid, dipterocarpol such as brain, caryophyllene, has pain relieving, sterilization is made
With, multiple pathogenic bacteria there is is suppression itching-relieving action, can effectively gingiva affected part be sterilized.
Herba Asari: acrid in the mouth, warm in nature.There is analgesia anesthesia, antibacterial effect.Containing methyleugenol, N-isobutyl group dodecane
Four acrylamides, demethylcoclaurine, have significantly suppression sensory nerve effect, affected part can carry out analgesia, antibacterial disappear
Scorching.
Borax: sweet in the mouth, salty, cool in nature.There is heat-clearing and toxic substances removing, effect of sterilization, containing sodium tetraborate, gum lobe mucosa is had
Long-acting bactericidal effect very well.
Claims (4)
1. gingiva breakage anti-inflammatory lozenge, it is characterised in that: described buccal tablet is made up of by four kinds of following mass parts following mass parts
Pulverizing and last make oral buccal tablet, four kinds of components are: Radix Aconiti Kusnezoffii 8-11, Borneolum Syntheticum 5-15, Herba Asari 2-8, Borax 4-10.
Gingiva breakage anti-inflammatory lozenge the most according to claim 1, it is characterised in that: four kinds of formation buccal tablet consist of: raw
Radix Aconiti Kusnezoffii 8, Borneolum Syntheticum 5, Herba Asari 2, Borax 4.
Gingiva breakage anti-inflammatory lozenge the most according to claim 1, it is characterised in that: four kinds of formation buccal tablet consist of: raw
Radix Aconiti Kusnezoffii 9, Borneolum Syntheticum 7, Herba Asari 5, Borax 6.
Gingiva breakage anti-inflammatory lozenge the most according to claim 1, it is characterised in that: four kinds of formation buccal tablet consist of: raw
Radix Aconiti Kusnezoffii 11, Borneolum Syntheticum 15, Herba Asari 8, Borax 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610470287.3A CN105878430A (en) | 2016-06-26 | 2016-06-26 | Anti-inflammatory buccal tablet for gingival damage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610470287.3A CN105878430A (en) | 2016-06-26 | 2016-06-26 | Anti-inflammatory buccal tablet for gingival damage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105878430A true CN105878430A (en) | 2016-08-24 |
Family
ID=56718274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610470287.3A Withdrawn CN105878430A (en) | 2016-06-26 | 2016-06-26 | Anti-inflammatory buccal tablet for gingival damage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105878430A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158103A (en) * | 2017-07-27 | 2017-09-15 | 陈魏魏 | The lozenge that children use dental transitional period |
| CN109106768A (en) * | 2018-11-12 | 2019-01-01 | 张瑞武 | A kind of lozenge for treating swelling and aching of gum |
-
2016
- 2016-06-26 CN CN201610470287.3A patent/CN105878430A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158103A (en) * | 2017-07-27 | 2017-09-15 | 陈魏魏 | The lozenge that children use dental transitional period |
| CN109106768A (en) * | 2018-11-12 | 2019-01-01 | 张瑞武 | A kind of lozenge for treating swelling and aching of gum |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10369182B2 (en) | Compositions and methods for treating insomnia and other sleep related disorders | |
| US20230310535A1 (en) | Oral rinse for management of post-oral surgical recovery and maintenance of oral health | |
| CN112022920A (en) | Traditional Chinese medicine dentifrice and preparation method and application thereof | |
| CN104095974B (en) | A kind of toothache buccal tablet and preparation method thereof | |
| CN105878430A (en) | Anti-inflammatory buccal tablet for gingival damage | |
| CN103127364B (en) | Traditional Chinese medicinal infusion for treating toothaches | |
| CN102895472A (en) | Topical combination medicament for treating dental ulcer and preparation method thereof | |
| CN104983752B (en) | A kind of Chinese medicine composition that treating mouth disease, oral-cavity article and preparation method | |
| CN103099881B (en) | External traditional Chinese medicine composition for treating toothache | |
| WO2010010394A2 (en) | Local pharmaceutical compositions | |
| CN102228638B (en) | Chinese medicinal preparation for treating toothache | |
| CN104013819A (en) | Wisdom tooth residual gap filling ointment | |
| WO2020079717A1 (en) | Ozonized phytotherapic composition for tissue and bone regeneration | |
| Bassiouny et al. | The anti-plaque effect of Miswak and myrrh mouthwashes versus chlorhexidine in the treatment of chronic gingivitis; a comparative clinical trial | |
| CN103100020A (en) | Traditional Chinese medicine preparation for treating toothache | |
| CN104225255A (en) | Medicament for relieving pain induced by wisdom tooth | |
| CN102552086B (en) | Tooth-fixing and pain-eliminating gargle | |
| CN105031477A (en) | Oral cavity and esophagus sterilization agent after swimming | |
| CN103007048A (en) | Ointment for treating blind pouches | |
| CN1301730C (en) | Medicine for treating decayed tooth and toothache | |
| CN107137458A (en) | A kind of Uygur medicine composition broken wall preparation and production method for treating mouth disease | |
| CN103751499A (en) | Chinese medicine composition for treating dental ulcer | |
| Rajendran et al. | Ayurveda in dental practice and its role in the management of dental diseases: A narrative review | |
| CN102793037A (en) | Fire-dispelling and inflammation-diminishing tea | |
| CN107412524A (en) | Treat the medicine of decayed tooth |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160824 |
|
| WW01 | Invention patent application withdrawn after publication |